Precision oncology, or the clinically and financially efficient use of genomically matched treatments and clinical trials, is evolving as a potentially important starting point for cancer care within ...

A real-world analysis found that comprehensive genomic profiling (CGP) in patients with non–small cell lung cancer (NSCLC) increases their therapy options patients and CGP testing needs to be utilized ...

Examining the relationship between cost of novel oncology drugs and their clinical benefit over time. Are surrogate endpoints unbiased metrics compared to hazard ratio for death? An evaluation of ...